Bill Ackman invests in young research scientists. Here are the first six to benefit. By Barbara Benson (Crain’s Business New York) – Home to some of the top medical institutions in the country, New York City attracts millions of dollars in annual federal research funding.
The Pershing Square Sohn Cancer Research Alliance today announced the winners of the inaugural Pershing Square Sohn Prize for Young Investigators in Cancer Research. Awarded to six New York City-based scientists at the Sohn Investment Conference, the Prize winners will each receive $200,000 per year for up to three years to enable them to pursue cutting-edge research at a stage when traditional funding is lacking.
By Amanda Gordon (Bloomberg Business Week) – Three days after announcing a $17 million donation to Harvard, activist investor Bill Ackman disappeared into a roomful of scientists to decide where his and his wife’s next gift should go.
(PNAS Journal) – The long-held but erroneous assumption of never-ending rapid growth in biomedical science has created an unsustainable hypercompetitive system that is discouraging even the most outstanding prospective students from entering our profession—and making it difficult for seasoned investigators to produce their best work. This is a recipe for long-term decline, and the problems … Continued
The Pershing Square Sohn Cancer Research Alliance celebrated its inaugural dinner and awarding the Pershing Square Sohn Prize to six young, innovative scientists in New York City for cancer research.
By Teresa Tritch (The New York Times) – There has been an upsurge in philanthropy for scientific research by America’s billionaires. As documented by William J. Broad in a recent report for The Times, the sums are huge; the quests serious; the results impressive. Still, in size and scope, philanthropy pales in comparison to public … Continued
By William J. Broad (The New York Times) – Funding the Future – As government financing of basic science research has plunged, private donors have filled the void, raising questions about the future of research for the public good.
Dramatically fewer grants are going to young scientists. That’s a cause for alarm. By Ronald J. Daniels and Paul Rothman (The Wall Street Journal) – Youth will be served, as the saying goes, but increasingly that’s not the case in scientific research. The National Institutes of Health reports that between 1980 and 2012, the share … Continued
Treatment Eradicated Tumors in 14 of 16 Patients With Advanced Leukemia in Study By Ron Winslow (The Wall Street Journal) – A technique to genetically modify a patient’s own immune cells eradicated tumors in 14 of 16 patients with advanced leukemia—at least for a time—in a study that adds to growing enthusiasm for efforts to … Continued
By Lauren Pecorino, PhD (The Huffington Post) – I may have written my book Why Millions Survive Cancer: The Successes of Science a little too early. In this book I compiled evidence that progress was being made in the field of cancer.